Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
Laboratoire de pathologie
Québec, Québec
Canada G1S 4L8

Dernières nouvelles

25 enregistrements « 2 de 3 »

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C

Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer.

Article de revue

Anticancer Res, 37 (6), p. 3323-3329, 2017, ISSN: 0250-7005.

Résumé | Liens:

Furrer D, Lemieux J, Cote MA, Provencher L, Laflamme C, Barabe F, Jacob S, Michaud A, Diorio C

Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.

Article de revue

Breast, 30 , p. 191-196, 2016, ISSN: 0960-9776.

Résumé | Liens:

Diorio C, Provencher L, Morin J, Desbiens C, Poirier B, Poirier E, Hogue JC, Jacob S, Cote G

Is there an Upgrading to Malignancy at Surgery of Mucocele-Like Lesions Diagnosed on Percutaneous Breast Biopsy?

Article de revue

Breast J, 22 (2), p. 173-9, 2016, ISSN: 1075-122X.

Résumé | Liens:

Diorio C, Furrer D, Michaud A, Laberge S, Popa I, Jacob S, Provencher L, Hogue JC

Validation of EP1 Antibody Clone for Estrogen Receptor Immunohistochemistry for Breast Cancer.

Article de revue

Anticancer Res, 36 (1), p. 435-7, 2016, ISSN: 0250-7005.

Résumé | Liens:

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C

Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer.

Article de revue

Anticancer Res, 36 (9), p. 4661-6, 2016, ISSN: 0250-7005.

Résumé | Liens:

Furrer D, Sanschagrin F, Jacob S, Diorio C

Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens.

Article de revue

Am J Clin Pathol, 144 (5), p. 686-703, 2015, ISSN: 0002-9173.

Résumé | Liens:

Hanna M, Dumas I, Jacob S, Tetu B, Diorio C

Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal women.

Article de revue

Menopause, 22 (9), p. 964-75, 2015, ISSN: 1072-3714.

Résumé | Liens:

Hogue JC, Morais L, Provencher L, Desbiens C, Poirier B, Poirier E, Jacob S, Diorio C

Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.

Article de revue

Anticancer Res, 34 (3), p. 1183-91, 2014, ISSN: 0250-7005.

Résumé | Liens:

Lemieux J, Diorio C, Cote MA, Provencher L, Barabe F, Jacob S, St-Pierre C, Demers E, Tremblay-Lemay R, Nadeau-Larochelle C, Michaud A, Laflamme C

Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.

Article de revue

Anticancer Res, 33 (6), p. 2569-76, 2013, ISSN: 0250-7005.

Résumé | Liens:

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

Article de revue

Diagn Pathol, 8 , p. 17, 2013.

Résumé | Liens:

25 enregistrements « 2 de 3 »
Signaler des ajouts ou des modifications